Autologous T Cells Transduced With A Retroviral Vector Encoding A Chimeric Antigen Receptor Against Gd2, Ex-Vivo Expanded

2 trials 2 recruiting LOncology

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

1 Countries

Phase I (Other)

Phase I (FiH)

Phase I (Other): 1 Phase I (FiH): 1

Sponsors using this IMP

Ospedale Pediatrico Bambino Gesu 2

All trials

2 total

Phase I/II study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric patients affected by High Risk and/or relapsed/refrac… Recruiting

2024-520436-15-00 Phase I (FiH) 1 country Ospedale Pediatrico Bambino Gesu
Phase I study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric and young adult patients affected by relapsed/refractory… Recruiting

2024-519168-42-00 Phase I (Other) 1 country Ospedale Pediatrico Bambino Gesu

Showing 1–2 of 2 trials

← All drugs A–Z